Fluvastatin |
Lescol |
Fluvastatin Systematic (IUPAC) name 7-[3-(4-fluorophenyl) -1-(1-methylethyl) -1H-indol-2-yl]-3, 5-dihydroxy-hept-6-enoic acid Identifiers CAS number 93957-54-1 ATC code C10AA04 PubChem 1548972 DrugBank APRD00346 Chemical data Formula C24H26FNO4 Mol. weight 411.466 g/mol Pharmacokinetic data Bioavailability ? Protein binding 98% Metabolism ? Half life 2.5 hours Excretion ? Therapeutic considerations Pregnancy cat. ? Legal sta ...
Wikipedia - [full article]
Fluvastatin Clinical Trials
- Other Effects of Fluvastatin Are Investigated
ClinicalTrials.gov Identifier: NCT00138528 - Active, not recruiting
Metabolic Syndrome
- Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone
ClinicalTrials.gov Identifier: NCT00171288 - Completed
Dyslipidemia
- Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers
ClinicalTrials.gov Identifier: NCT00171262 - Active, not recruiting
Dyslipidemia
- Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00385658 - Active, not recruiting
Dyslipidemia
- Efficacy and Tolerability of Fluvastatin in Adults with Dislipidemia with History of Muscle Problems
ClinicalTrials.gov Identifier: NCT00125125 - Completed
Dyslipidemia
- Fluvastatin Versus Hepatitis C Virus
ClinicalTrials.gov Identifier: NCT00441493 - Active, not recruiting
Hepatitis C
- Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors
ClinicalTrials.gov Identifier: NCT00382161 - Recruiting
Impotence
- Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.
ClinicalTrials.gov Identifier: NCT00404287 - Recruiting
Aortic Valve Stenosis
- Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer
ClinicalTrials.gov Identifier: NCT00416403 - Recruiting
Breast Cancer
- Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)
ClinicalTrials.gov Identifier: NCT00549926 - Recruiting
Coronary Disease; Hypercholesterolemia
- Efficacy and Safety of Fluvastatin in Different Doses in Adults with Mixed Dyslipidemia or Primary Hypercholesterolemia
ClinicalTrials.gov Identifier: NCT00136799 - Completed
Mixed Dyslipidemia; Hypercholesterolemia
- A Randomized, Controlled Trial of Fluvastatin Added to Pegylated Interferon and Ribavirin (PI+R) Versus PI+R Alone for Treatment of Chronic Hepatitis C Not Previously Treated
ClinicalTrials.gov Identifier: NCT00487318 - Recruiting
Chronic Hepatitis C
- Fluvastatin After Heart Transplantation
ClinicalTrials.gov Identifier: NCT00421005 - Recruiting
Heart Transplantation; Hypercholesterolemia
- Effect of Fluvastatin on Top of Clopidogrel and Aspirin in Patients After DES Implantation on Platelet Aggregation
ClinicalTrials.gov Identifier: NCT00465322 - Completed
Drug-Interactions
- Fluvastatin in the Therapy of Acute Coronary Syndrome
ClinicalTrials.gov Identifier: NCT00171275 - Completed
Coronary Disease; Myocardial Infarction
- Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction
ClinicalTrials.gov Identifier: NCT00171327 - Completed
Hypertension; Dyslipidemia
- Investigation of the Steady State Pharmacokinetics of Tacrolimus, Mycophenolate Mofetil and Fluvastatin After Renal Transplantation
ClinicalTrials.gov Identifier: NCT00223015 - Completed
Renal Transplantation
- Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation
ClinicalTrials.gov Identifier: NCT00223028 - Completed
Renal Transplantation
- Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients Transplant
ClinicalTrials.gov Identifier: NCT00565474 - Completed
Graft Vasculopathy
- Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia
ClinicalTrials.gov Identifier: NCT00171236 - Completed
Heterozygous Familial Hypercholesterolemia; Mixed Dyslipidemia
- Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-Menopausal Women With Low Bone Mass
ClinicalTrials.gov Identifier: NCT00489424 - Completed
Low Bone Mass
Resources
- Fluvastatin (Drug Digest)
- Fluvastatin (Cleveland Clinic)

Not Signed In -

